Evidence map›Paper›PMID 42079712›Full record

ArticleHealth science reports2026

Advances in Gene Therapy for Xerostomia: Current Perspectives and Future Directions: A Narrative Review.

Muhammad Usman Bilal, Sarah Alvi, Fatima Humayune, Hasan Mujtaba, Shahzad Ahmad, Shazia Iqbal, Muhammad Farooq Umer

Abstract read
In one paragraph

Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Muhammad Usman BilalSchool of Dentistry Shaheed Zulfiqar Ali Bhutto Medical University Islamabad Pakistan.ORCID https://orcid.org/0009-0003-1969-7610
Sarah AlviSindh Institute of Oral Health Sciences Jinnah Sindh Medical University Karachi Pakistan.ORCID https://orcid.org/0009-0001-5522-535X
Fatima HumayuneSchool of Dentistry Shaheed Zulfiqar Ali Bhutto Medical University Islamabad Pakistan.ORCID https://orcid.org/0009-0008-2669-7586
Hasan MujtabaDepartment of Oral Pathology, School of Dentistry Shaheed Zulfiqar Ali Bhutto Medical University Islamabad Pakistan.
Shahzad AhmadFaculty of Medicine and Health Science The University of Buckingham Buckingham UK.ORCID https://orcid.org/0000-0002-3953-593X
Shazia IqbalFaculty of Medicine and Health Science The University of Buckingham Buckingham UK.ORCID https://orcid.org/0000-0003-4890-5864
Muhammad Farooq UmerDepartment of Preventive Dental Sciences, College of Dentistry King Faisal University Hofuf Al-Ahsa Saudi Arabia.ORCID https://orcid.org/0000-0001-7779-1929

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Xerostomia, or dry mouth, significantly impairs quality of life and oral health, particularly in patients subjected to radiation therapy or suffering from systemic disorders. This narrative review summarizes the current evidence on the efficacy and safety of gene therapy interventions for xerostomia, exploring innovative approaches such as viral vector-mediated delivery of aquaporin-1, growth factor-based strategies, and cutting-edge CRISPR techniques. Methods: We conducted a comprehensive literature search on gene therapy interventions for xerostomia to synthesize this narrative review. Results and Conclusion: A critical evaluation of these studies reveals promising advancements alongside current limitations in medical research, including off-site therapeutic effects, delivery efficiency, and long-term efficacy. This review thus provides a comprehensive perspective on current gene therapy strategies for xerostomia, setting the stage for future research to bridge the gap between experimental therapies and everyday clinical applications.

Indexed as

aquaporin‐1CRISPR‐Cas9gene therapysalivary gland regenerationxerostomia

Identifiers

PMID42079712
PMCPMC13129664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.